GlaxoSmithKline PLC Director/PDMR Shareholding (3201D)

TIDMGSK

RNS Number : 3201D

GlaxoSmithKline PLC

25 April 2017

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  =================================================================== 
 a)   Name                      Mr B McNamara 
===  =========================  ======================================== 
 b)   Position/status           CEO, Consumer Healthcare 
===  =========================  ======================================== 
 c)   Initial notification/     Initial notification 
       amendment 
===  =========================  ======================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =================================================================== 
 a)   Name                      GlaxoSmithKline plc 
===  =========================  ======================================== 
 b)   LEI                       5493000HZTVUYLO1D793 
===  =========================  ======================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =================================================================== 
 a)   Description of            American Depositary Shares ('ADSs') 
       the financial             ISIN: US37733W1053 
       instrument 
===  =========================  ======================================== 
 b)   Nature of the             Acquisition of Ordinary Shares following 
       transaction               the re-investment of dividends paid to 
                                 shareholders on 13 April 2017 on shares 
                                 held in the Deferred Annual Bonus Plan 
                                 Post-Tax - matching award. 
===  =========================  ======================================== 
 c)   Price(s) and                Price(s)   Volume(s) 
       volume(s)                  ---------  ---------- 
                                   $41.1461   28.716 
                                  ---------  ---------- 
===  =========================  ======================================== 
 d)   Aggregated information    n/a (single transaction) 
       Aggregated volume 
       Price 
===  =========================  ======================================== 
 e)   Date of the transaction   2017-04-25 
===  =========================  ======================================== 
 f)   Place of the              New York Stock Exchange (XNYS) 
       transaction 
===  =========================  ======================================== 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHQELFLDZFFBBQ

(END) Dow Jones Newswires

April 25, 2017 12:24 ET (16:24 GMT)